Last July, the government responded to recommendations from the Advisory Council on the Misuse of Drugs on reducing barriers to clinical research with Schedule 1 drugs, committing to set up a cross-government working group of officials to assist with delivery. The group had its 1st meeting in September, the next is planned for this month.


